Clinical and Biologic Effects of Metformin in Early Stage Breast Cancer
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The study will be testing metformin in patients with breast cancer who are about to undergo
surgery. Patients will take metformin 3 times daily for about 2-3 weeks prior to their
surgery date. It is hypothesized that metformin will reduce cell proliferation rates in
tumour tissue.